Form 4: STERIS Director Exercises Stock Options
Insider Transaction Report
STERIS plc Director Richard C. Breeden exercised stock options to acquire 4,110 ordinary shares at $64.05 per share.
Summary
- Richard C. Breeden, a Director of STERIS plc, exercised stock options on August 13, 2025.
- He acquired 4,110 ordinary shares at an exercise price of $64.05 per share.
- Following the exercise, Mr. Breeden directly owns 36,664 ordinary shares and indirectly owns 27,242 ordinary shares.
- The exercised option was fully vested and originated from STERIS plc's redomiciliation to Ireland in March 2019.
- The option to purchase 4,110 STERIS plc ordinary shares at $64.05 per share has now been fully exercised, resulting in 0 derivative securities of this type remaining.
Sentiment
Score: 7
Explanation: The exercise of stock options by a director to acquire shares is generally viewed positively as it indicates confidence in the company's future prospects, especially when the exercise price is below the current market price (though the current market price is not stated, the exercise itself implies value).
Positives
- A director is increasing their direct ownership in the company, which can signal confidence in future performance.
Future Outlook
This filing is a transactional report of insider activity and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.
Related Party Transactions
- The filing details indirect beneficial ownership through entities where Mr. Breeden serves as managing member, chairman, and CEO (Breeden Capital Management LLC, Breeden Capital Partners LLC, Breeden Partners L.P.), which could be considered related party arrangements for shareholding purposes.
Stakeholder Impact
- Shareholders: The director's increased direct ownership may be perceived as a positive signal of confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 2019-03-01 | Approximate date of STERIS plc redomiciliation to Ireland, when the stock option was received. |
| 2025-08-13 | Date of stock option exercise and acquisition of ordinary shares. |
| 2025-08-15 | Date the Form 4 was signed. |
| 2025-08-31 | Expiration date of the exercised stock option. |
Recommendation
holdThe exercise of stock options by a director to acquire additional shares is a positive signal, indicating insider confidence in the company's valuation and future prospects. However, this single transaction, without broader financial performance data or strategic updates, is insufficient to warrant a 'buy' or 'sell' recommendation. It reinforces a 'hold' position for existing investors, suggesting that the insider believes the stock has further upside or is at least fairly valued.
Keywords
STERIS plc, STE, Form 4, Insider Trading, Stock Option Exercise, Director, Richard C. Breeden, Share Acquisition, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.